Literature DB >> 22381260

In vitro toxicity screening of chemical mixtures using HepG2/C3A cells.

Omari J Bandele1, Michael F Santillo, Martine Ferguson, Paddy L Wiesenfeld.   

Abstract

Traditional toxicological methods that utilize only single pure compounds may not accurately predict risks from substances with multiple chemical constituents. A complementary approach to conventional methodologies includes in vitro systems that assess toxicity of chemical mixtures and identify components that may adversely impact biological processes. Compared to animal models, in vitro assays are inexpensive, rapid, and reduce and refine related animal testing. We utilized HepG2/C3A cells as a hepatotoxicity screening model to evaluate the cytotoxic and metabolic effects of three commercially available oil dispersants, Corexit EC9500A and EC9527A and ZI-400. The surfactant DOSS, a primary active constituent of the Corexit dispersants, was also evaluated. Biologically relevant endpoints were measured including cell viability, oxidative stress, and mitochondrial activity. Significant increases in cytotoxicity were observed with Corexit dispersants (LC(50)∼250 ppm), whereas ZI-400 was moderately cytotoxic (LC(50) >>400 ppm). Each dispersant caused an accumulation of reactive oxygen species and altered mitochondrial activity and other cellular processes. Generally, DOSS made notable contributions to the effects of EC9500A and EC9527A, however, they were observed at concentrations higher than those used in most consumer products. Overall, this system may represent a valuable complementary tool for predicting the toxicity of complex mixtures. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381260     DOI: 10.1016/j.fct.2012.02.016

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Effects of COREXIT dispersants on cytotoxicity parameters in a cultured human bronchial airway cells, BEAS-2B.

Authors:  Yongli Shi; Astrid M Roy-Engel; He Wang
Journal:  J Toxicol Environ Health A       Date:  2013

Review 2.  A perspective on the potential risks of emerging contaminants to human and environmental health.

Authors:  Lílian Cristina Pereira; Alecsandra Oliveira de Souza; Mariana Furio Franco Bernardes; Murilo Pazin; Maria Júlia Tasso; Paulo Henrique Pereira; Daniel Junqueira Dorta
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-24       Impact factor: 4.223

3.  STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.

Authors:  Omar Nunez Lopez; Fredrick J Bohanon; Xiaofu Wang; Na Ye; Tiziana Corsello; Yesenia Rojas-Khalil; Haijun Chen; Haiying Chen; Jia Zhou; Ravi S Radhakrishnan
Journal:  RSC Adv       Date:  2016-10-14       Impact factor: 3.361

4.  Testing the efficacy of broad-acting sorbents for environmental mixtures using isothermal analysis, mammalian cells, and H. vulgaris.

Authors:  Meichen Wang; Zunwei Chen; Ivan Rusyn; Timothy D Phillips
Journal:  J Hazard Mater       Date:  2020-10-28       Impact factor: 10.588

5.  Evaluation of Pulmonary and Systemic Toxicity of Oil Dispersant (COREXIT EC9500A(®)) Following Acute Repeated Inhalation Exposure.

Authors:  Jenny R Roberts; Stacey E Anderson; Hong Kan; Kristine Krajnak; Janet A Thompson; Allison Kenyon; William T Goldsmith; Walter McKinney; David G Frazer; Mark Jackson; Jeffrey S Fedan
Journal:  Environ Health Insights       Date:  2015-02-09

Review 6.  Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials.

Authors:  Melissa Anne Tutty; Dania Movia; Adriele Prina-Mello
Journal:  Drug Deliv Transl Res       Date:  2022-05-04       Impact factor: 5.671

7.  Corexit-EC9527A Disrupts Retinol Signaling and Neuronal Differentiation in P19 Embryonal Pluripotent Cells.

Authors:  Yanling Chen; David H Reese
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

8.  Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.

Authors:  Leonard J Nelson; Katie Morgan; Philipp Treskes; Kay Samuel; Catherine J Henderson; Claire LeBled; Natalie Homer; M Helen Grant; Peter C Hayes; John N Plevris
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-07-15       Impact factor: 4.080

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.